EVLO
$4.69
Evelo Biosciences
($.09)
(1.88%)
EVLO
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.50)
Revenue:  $0.00 Mil
Thursday
Jan 28
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when EVLO reports earnings?
Beat
Meet
Miss

Where is EVLO's stock price going from here?
Up
Flat
Down
Stock chart of EVLO
Analysts
Summary of analysts' recommendations for EVLO
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Evelo Biosciences, Inc. operates as a bio-technology company. It develops therapies for the treatment of the gut-body network. The company also offers treatment for cancer and inflammatory diseases. Its product portfolio consists of EDP1066 which are in clinical stage. Evelo Biosciences is based in Massachusetts, United States.